COVID-19, like most illness caused by other coronaviruses, is mainly a disease of the respiratory system. However, doctors throughout the world have observed that people with high blood pressure or stroke survivors may be more vulnerable to serious complications after COVID-19 diagnosis.
In addition, physicians in highly COVID-19 prevalent locations such as NYC are reporting an increased occurrence of major large artery blockage stroke in otherwise young people without classic stroke risk factors.
Despite these observations and despite effective treatments for acute stroke, alarmingly, many hospitals in the US have seen a significant decrease in the average number of patients presenting to the hospital with stroke signs or symptoms.
Efforts to understand how SARS-coV-2 is connected to high blood pressure and stroke are complicated by a lack of rigorous studies.
However, growing evidence suggests that COVID-19 infection can cause the blood to clot in unusual ways throughout the body and that the virus may also directly induce head or neck artery blocking or narrowing events.
Protecting yourself from exposure to the virus, continuing to take all your medications as prescribed, ensuring that you are eating a healthy diet and getting regular physical activity will help maintain your heart and brain health.
And, of course, it is a good idea to avoid tobacco smoking, vaping, alcohol and recreational drug abuse.
The Center for Disease Control or the World Health Organization (WHO) COVID-19 provide comprehensive up-to-date information regarding safety, symptoms, what do to if someone has been infected, research breakthroughs, travel advice or strategies and plans for reopening the economy.
Meanwhile, JTSSF is steadfast in their commitment to fund and accelerate potentially life-saving stroke research.
JTSSF is a charitable foundation dedicated to preventing stroke and optimizing stroke treatment and recovery.
Founded in 2009 by Dr Jeffrey Thomas, a cerebrovascular neurosurgeon at Washington Hospital in Fremont, CA with special expertise and interest in stroke, Dr Thomas believes that prevention of stroke is among the most important and achievable medical tasks of the 21st century, with tremendous potential for public health impact.
JTSSF is unique in that it focuses on stroke-related research only.
LivaNova announces commercial launch of Essenz Perfusion System in China
Viatris' generic iron sucrose injection gains US FDA approval
CorMedix to acquire Melinta Therapeutics in USD300m deal to expand infectious disease portfolio
US FDA approves Innovent's IND application for IBI3032 oral GLP-1R agonist
GEN and Sulfateq report positive Phase 1 data for SUL-238 in Alzheimer's
Philips launches ECG AI Marketplace to streamline cardiac diagnostics
AstraZeneca's Baxdrostat meets all endpoints in pivotal Phase III hypertension trial
Accord Healthcare introduces Dehydrated Alcohol Injection for cardiovascular indications
Innovent presents mazdutide Phase 3 clinical study results at ADA 85th Scientific Sessions
Breckenridge Pharmaceutical's generic for Ablysinol granted final FDA approval
Cumberland Pharmaceuticals reports ifetroban Phase 2 DMD heart disease trial results
EDX Medical and Spire Healthcare sign strategic diagnostic partnership agreement